IBS (Irritable Bowel Syndrome)

Definition

IBS affects an estimated 10 to 15% of the population and is significantly more prevalent in women — particularly in the 20 to 50 age range. It is classified into subtypes: IBS-D (diarrhea-predominant), IBS-C (constipation-predominant), and IBS-M (mixed). IBS is a diagnosis of exclusion — it requires ruling out inflammatory bowel disease, celiac disease, infection, and other structural pathology. The mechanisms underlying IBS include gut-brain axis dysregulation, visceral hypersensitivity, altered gut motility, dysbiosis, intestinal permeability, and low-grade intestinal inflammation. The association between IBS and anxiety, depression, and stress is well documented — the gut-brain axis mediates bidirectional communication between the gut and the central nervous system. Hormonal fluctuations — including those of perimenopause — significantly affect IBS severity, which is why IBS symptoms often worsen during hormonal transitions.

Frequently Asked Question

What causes IBS?

IBS is not caused by a single factor — it is driven by multiple interacting mechanisms: gut microbiome dysbiosis, intestinal permeability, altered gut motility, visceral hypersensitivity (the gut pain system is more reactive than normal), gut-brain axis dysregulation, and often a history of gut infections or antibiotic use that disrupted the microbiome. Food sensitivities are common triggers. Stress and hormonal fluctuations significantly influence symptom severity through the gut-brain and hormonal-gut axes.

How do hormones affect IBS?

Estrogen and progesterone directly influence gut motility, intestinal permeability, and visceral pain sensitivity — which is why many women experience IBS flares at specific phases of their menstrual cycle and why symptoms frequently worsen during perimenopause when hormone levels fluctuate erratically. At SPOKEmed, the hormonal component of IBS is evaluated through comprehensive hormone testing — including the DUTCH test when hormonal pattern detail is needed — alongside GI-MAP gut assessment. Treating the gut without addressing hormones in a perimenopausal woman with IBS produces incomplete results; both systems need evaluation.

Can gut testing identify IBS triggers?

Yes. GI-MAP testing can identify specific dysbiosis patterns, pathogenic overgrowths, and inflammation markers that are driving IBS symptoms — providing a far more actionable picture than an IBS diagnosis alone. For example, elevated Blastocystis or other parasites, SIBO-associated bacterial overgrowth patterns, or significant dysbiosis in specific genera all suggest different targeted interventions. Testing transforms IBS management from trial-and-error to evidence-guided protocol.

Why IBS (Irritable Bowel Syndrome) Matters

Many women managing IBS have been given little clinical explanation beyond 'it's stress-related' and a fiber supplement recommendation. Understanding the biological mechanisms — dysbiosis, intestinal permeability, gut-brain axis dysregulation, and hormonal connection — opens the door to a fundamentally different approach. At SPOKEmed, IBS is investigated through GI-MAP testing to identify specific microbial drivers, permeability status, and inflammation levels, then treated with targeted protocols addressing those specific findings — not generic symptom management. The goal is not to manage IBS indefinitely but to identify and correct its underlying cause.

How Spokmed Company Uses It

SPOKEmed approaches IBS through comprehensive gut health evaluation including GI-MAP testing, which identifies specific dysbiosis patterns, inflammation markers, and permeability status that often underlie IBS symptoms. Targeted protocols address root causes rather than managing symptoms with antispasmodics or fiber supplements alone.

Related Services

Related Terms

"IBS (Irritable Bowel Syndrome)" Appears in These Categories

Gut Health & Microbiome Optimization